Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jun;26(3):109-112.
doi: 10.1016/j.jaapos.2022.03.003. Epub 2022 Apr 23.

Retinopathy of prematurity classification updates: possible implications for treatment

Alistair R Fielder  1 , Graham E Quinn  2 , R V Paul Chan  3 , Gerd E Holmström  4 , Michael F Chiang  5 ; ICROP 3 Classification Committee
Collaborators, Affiliations
Editorial

Retinopathy of prematurity classification updates: possible implications for treatment

Alistair R Fielder et al. J AAPOS. 2022 Jun.
No abstract available

PubMed Disclaimer

Figures

FIG 1.
FIG 1.
This image was designated in 2005 as preplus, but in 2021, this same image was judged by a panel of experts to represent plus disease. Permission to reproduce previously published image from Arch Ophthalmol 2005;123:991–9.
See this image and copyright information in PMC

References

    1. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 2003;121:1684–94. - PubMed
    1. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 2005;123:991–9. - PubMed
    1. Chiang MF, Quinn GE, Fielder AR, et al. International Classification of Retinopathy of Prematurity, Third Edition. Ophthalmology 2021;128:e51–e68. - PMC - PubMed
    1. Mintz-Hittner HA, Kennedy KA, Chuang AZ, BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 31 retinopathy of prematurity. N Engl J Med 2011;364:603–15. - PMC - PubMed
    1. Stahl A, Lepore D, Fielder A, et al. Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial. Lancet 2019;394(10208):1551–9. - PMC - PubMed

Publication types

LinkOut - more resources